Sandoz Group AG (SWX:SDZ)
73.84
+0.24 (0.33%)
Aug 21, 2026, 5:31 PM CET
Sandoz Group AG Revenue
Sandoz Group AG had revenue of $5.78B USD in the half year ending June 30, 2026, with 14.26% growth. This brings the company's revenue in the last twelve months to $11.68B, up 10.29% year-over-year. In the year 2025, Sandoz Group AG had annual revenue of $11.16B with 7.44% growth.
Revenue (ttm)
$11.68B
Revenue Growth
+10.29%
P/S Ratio
3.39
Revenue / Employee
$583.80K
Employees
20,000
Market Cap
31.95B CHF
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.16B | 773.00M | 7.44% |
| Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
| Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
| Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
| Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
| Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.96B |
| Novartis AG | 45.81B |
| Alcon | 8.78B |
| Lonza Group AG | 6.87B |
| Galderma Group AG | 4.79B |
| Galenica AG | 4.29B |
| Sonova Holding AG | 3.61B |
| Straumann Holding AG | 2.64B |
Sandoz Group AG News
- 5 days ago - Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform - PRNewsWire
- 5 days ago - Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech - Reuters
- 11 days ago - Sandoz price target raised to CHF 80 from CHF 75 at JPMorgan - TheFly
- 17 days ago - Sandoz Shares Climb After Biosimilar Sales Drive Growth - WSJ
- 17 days ago - Sandoz Group AG Earnings Call Transcript: Q2 2026 - Transcripts
- 17 days ago - Sandoz Group AG Slides: Q2 2026 - Filings
- 17 days ago - Sandoz Group AG Quarterly report: Q2 2026 - Filings
- 17 days ago - Sandoz Group AG Earnings release: Q2 2026 - Filings